(SD) age 48 (5.7) years) able to exercise 3 weeks after infarction and who agreed to undergo coronary angiography were recruited to a study group and seen 18 months, and 3, 5, and 7 years after MI. In addition, a cross sectional analysis of survival was made to a median of 120 months. Seventy 3 month survivors (mean (SD) age 48 (5.8) years) were not recruited to the study group but were traced for late survival through their general practitioners and family health service associations to a median of 130 months. Main outcome measures-Survival in young patients after MI and the survival of 3 month survivors stratified by their ability to exercise and agreement to undergo angiography. The rate of coronary artery surgery (CAGB) and reinfarction during the first 7 years after index MI in patients recruited to the study group. Results-Sixteen patients (6%) died in hospital and eight (3%) within 3 months of the index infarction. The 7 and 11 year survival rates in the whole cohort of 255 patients were 80% and 66% respectively using life table methods. Survival 7 years after MI, in patients recruited to the study group was better than in those not recruited (93% v 79%, P = 0X001), but thereafter mortality in the study group accelerated and there was no significant difference in survival 11 years after infarction (76% v 67%, P = 0.05). There was a trend towards higher mortality in patients with multivessel disease and severely impaired left ventricular function. During the first 7 years after MI, 38 of 150 patients in the study group underwent CABG and 19 suffered reinfarction, which was fatal in three. Conclusion-The medium-term prognosis of young survivors of MI is good, particularly in patients recruited to the study group. After 7 years there is an increase in mortality and the long-term prognosis is less favourable. This should be taken into account when planning future management and follow up of young patients after MI.
(Br HeartJa 1995;74:604-6 10)
Keywords: acute myocardial infarction, prognosis after infarction in young patients, survival after infarction in young patients
Patients are naturally anxious about their prognosis after recovery from an acute myocardial infarction. Age along is an independent indicator of good prognosis in hospital and at 1 year after infarction.1 2 Younger patients also tend to have less extensive coronary artery disease and better left ventricular function with 3 year survival rates for patients aged 60 years or less after infarction of 93-95%.3 4 The long-term prognosis of young patients after infarction is less well studied, however, and longer term follow up studies are essential to provide this information. We report the survival data from a cohort of 255 patients aged 55 fference between groups an ejection fraction of less than 20%; two have died and one has undergone transplantation. Figure 5 is a plot of estimated hazard function of the two groups. The general pattern for risk of dying in patients in the study group remains roughly constant during the first 7 years after which it appears to increase. By contrast, the mortality risk of patients excluded from the study group is higher with no distinct trend. Survival time (months) Figure 5 Life table estimate of the hazardfunction ofpatients with respect to recruitment to the study group illustrating the risk ofpatients dying in the two separate groups during different time intervals. The risk ofpatients dying in the study group remains roughly constant during thefirst 7 years after which it appears to increase. By contrast, the mortality risk ofpatients excludedfrom the study is higher with no distinct change with time.
Comparison of mortality in patients recruited and those not recruited to the study group Table 2 shows the cumulative life table survival of the total cohort (including inhospital and early out of hospital deaths) and that of 3 month survivors in the study group and excluded group at 7, 9, and 11 years. The differences in survival between the study group and non-study group are significant at 7 years (P = 0-001) but not at 11 years (P = 0'05). 10 We report survival in our cohort as a whole with follow up data in 96% of all patients. We also report survival in 3 month survivors stratified by ability to exercise and agreement to angiography. We elected to consider the patient undergoing cardiac transplantation as having "died" (without transplantation she would almost certainly have died and we therefore feel this is justified, although the time of her "death" which we used may have been a little premature). Table 5 summarises survival in patients after acute myocardial infarction in published series. The inhospital mortality of our patients is comparable with that reported elsewhere of all patients under the age of 70 years." Survival in our patients, including those who died in hospital or soon after discharge, seems at least as good and possibly better than in published series with one exception" (table 5). We have not yet reached 15 years of follow up, however, and as there is a clear trend towards an acceleration in mortality after 7 years the mortality of our cohort may approach that of others. Roth et al"3 report much lower mortality which seems in sharp contrast to our own findings and those of others. In the study of Roth et al, however, the survival status of only 10 patients beyond 10 years is reported and the confidence intervals, although not shown, must be wide.
Fioretti et al'4 demonstrated a pronounced difference in mortality 1 year after infarction between patients of all ages who could exercise (7%) and those who could not do so for cardiac reasons (56%). As cardiac disability was not the only indication for exclusion from our study group, the absolute mortality in patients not enrolled in the study group and the difference between the groups are less noticeable.
Norris et a19 also found a significant difference in mortality after infarction between patients stratified by agreement to angiography and ability to exercise 4 weeks after infarction (13% v 33% during a mean follow up of 3-5 years). Although we too found that mortality in patients recruited to angiography and exercise testing is lower than those excluded, mortality in our patients in both groups is lower than reported by Norris et al. Our patients are a little younger-that is, less than 56 years compared with less than 60 years, and angiographically Table S Survival ofpatients with acute myocardial infarction from published series (with dates of recruitment) before routine thrombolysis. The number ofpatients studied and any exclusionlinclusion criteria are shown. The number of patients available for calcation of % survival is indicated where this data could be extractedfrom the paper. The (table 5 ). By contrast, the prevalence of multivessel disease is slightly higher in our study, (41%) than in the study by Roubin et al (36%). We have found that 7 years after infarction the survival of patients in the study group remains good and the difference from those excluded reaches significance. Beyond this, however, the risk of dying in patients in the study group increases. The pattern of risk for patients in the excluded group is less clear as the decline between 8 and 10 years must be interpreted with caution as there were few deaths during this time interval. The apparent absence of any significant difference in survival between the two groups 11 years after infarction must be considered with the reduction in the number of patients in mind. However, patients who are not recruited to investigation more often have other serious illnesses. Patients with severe symptomatic heart failure are often unable to exercise and are therefore excluded, although their prognosis is poor. Consequently, patients who are not recruited may die earlier, although the total mortality may not differ between the two groups if follow up is sufficiently long.
After 7 years, only 13% of our patients suffered a recurrent infarction, 16% of which were fatal. Other studies (table 6) have tended to report a higher rate of reinfarction, although studies of a similar duration and restricted to patients of a similar age to ours are lacking. Although our rate of recurrent infarction is probably lower than in other studies, the reinfarction rate applies only to patients recruited to the study group and only up to 7 years after infarction. We have already shown that the prognosis of patients excluded from the study group is worse than those recruited and this may apply, not only to survival, but also to recurrent infarction. Similarly, as the mortality of recruited patients tends to accelerate after 7 years, so may the rate of reinfarction.
The ejection fraction39 and number of diseased vessels3 after infarction in patients aged 60 years or less are independent predictors of survival. Age is also an independent predictor of prognosis after infarction, although younger patients also tend to have less extensive coronary artery disease and better preserved left ventricular function. However, our young patients had a relatively high rate of coronary artery surgery, namely, 38 of the 150 patients in the study group having been operated on The medium-term survival in young survivors after a myocardial infarction is good but mortality increases after 7 years. These findings should be taken into account when planning future management and follow up protocols of young survivors of acute infarction. Moreoever, investigation of patients without prior coronary artery surgery to identify those who have progressed from a low risk to a high risk group and the judicious use of coronary artery surgery in these patients should possibly be considered. Attention to other chronic, prognostic treatment is also required in young patients at all stages after infarction.
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